1. Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men.
   Kaydos-Daniels SC, Miller WC, Hoffman I, Banda T, Dzinyemba W, Martinson F, Cohen MS, Hobbs MM.
   J Clin Microbiol 2003;41:318-323.

summary                expert review

2. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.
   Gaydos CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin DH, Ferrero DV, Schachter J.
   J Clin Microbiol 2003;41:304-309.

summary               

3. Determination of immunoglobulin A against Gardnerella vaginalis hemolysin, sialidase, and prolidase activities in vaginal fluid: implications for adverse pregnancy outcomes.
   Cauci S, Thorsen P, Schendel DE, Bremmelgaard A, Quadrifoglio F, Guaschino S.
   J Clin Microbiol. 2003;41:435-438.

summary                expert review

4. Detection of Mycoplasma genitalium by PCR amplification of the 16S rRNA gene.
   Jensen JS, Borre MB, Dohn B.
   J Clin Microbiol. 2003;41:261-266.

summary                expert review

5. Evaluation of an enzyme immunoassay technique for detection of antibodies against Treponema pallidum.
   Castro R, Prieto ES, Santo I, Azevedo J, da L. Exposto F
   J Clin Microbiol. 2003;41:250-253.

summary                expert review

6. Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae.
   Palmer HM, Mallison H, Wood RL, Herring AJ.
   J Clin Microbiol. 2003;41:835-837.

summary                expert review

7. Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors.
   Chong S, Jang D, Song X, Mahony J, Petrich A, Barriga P, Chernesky M.
   J Clin Microbiol. 2003;41:778-782.

summary                expert review

8. Diagnosing herpesvirus infections by real-time amplification and rapid culture.
   van Doornum GJJ, Guldemeester J, Osterhaus ADME, Niesters HGM.
   J Clin Microbiol. 2003;41:576-580.

summary                expert review

9. Longitudinal reliability of Focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women.
   Cherpes TL, Ashley RL, Meyn LA, Hillier SL.
   J Clin Microbiol. 2003;41:671-674

summary                expert review

10. Relation between Gram-stain and clinical criteria for diagnosing bacterial vaginosis with special reference to Gram grade II evaluation.
    Taylor-Robinson D, Morgan DJ, Sheehan M, Rosenstein IJ, Lamont RF.
    Int J STD AIDS 2003;14:6-10.

summary                expert review

11. An internal control DNA is useful for the detection of PCR inhibitors in urine samples analyzed for C. trachomatis DNA by PCR.
    Betsou F, Beaumont K, Sueur JM, Orfila J.
    J Clin Microbiol. 2003;41:1274-1276.

summary                expert review

12. Improved sensitivity of the Chlamydia trachomatis Cobas Amplicor using an optimized procedure for preparation of specimens.
    Niederhauser C, Kaempf L.
    Eur J Clin Microbiol. 2003;22:118-121.

summary                expert review

13. Evaluation of a novel diagnostic test for bacterial vaginosis: ‘the electronic nose’.
    Hay P, Tummon A, Ogunfile M, Adebiyi A, Adefowora A.
    IntJ STD AIDS 2003;14:114-118.

summary                expert review

14. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.
    Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL.
    Clin Infect Dis. 2003;36:663-668.

summary                expert review

15. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based Papanicolaou smear.
    Lara-Torre E, Pinkerton JS.
    Am J Obstet Gynecol. 2003;188:354-356.

summary                expert review

16. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease.
    Yudin MH, Hillier SL, Wiesenfeld HC, Krohn MA, Amortegui AA, Sweet RL
    Am J Obstet Gynecol 2003;188:318-323.

summary                expert review

17. “Shelf life” of Trichomonas vaginalis
    Kingston MA, Bansal D, Carlin EM. “Shelf life” of Trichomonas vaginalis.
    Int J STD AIDS. 2003;14:28-29.

summary                expert review

18. Performance characteristics of a glycoprotein G based oligopeptide (peptide 55) and two different methods using the complete glycoprotein as assays for detection of anti-HSV-2 antibodies in human sera.
    Nilsen A, Ulvestad E, Marsden H, Langeland N, Myrmel H, Matre R, Haarr L.
    J Virol Meth. 2003;107:21-27.

summary                expert review

19. Phenotypic and genotypic methods for the detection of herpes simplex virus serotypes.
    Madhavan HN, Priya K, Bagyalakshmi R.
    J Virol Meth. 2003;108:97-102.

summary                expert review

20. A novel polymerase chain reaction assay to detect Mycoplasma genitalium.
    Eastick K, Leeming JP, Caul EO, Horner PJ, Millar MR.
    J Clin Pathol: Mol Pathol. 2003;56:25-28.

summary                expert review

21. Measurement of IgG antibodies to Chlamydia trachomatis by commercial enzyme immunoassays and immunofluorescense in sera from pregnant women and patients with infertility, pelvic inflammatory disease, ectopic pregnancy, and laboratory diagnosed Chlamydia psittaci/Chlamydia pneumoniae infection.
    Jones CS, Maple PAC, Andrews NJ, Paul ID, Caul EO.
    J Clin Pathol. 2003;56:225-230.

summary                expert review

22. Chancroid: clinical manifestations, diagnosis, and management.
    Lewis DA.
    Sex Transm Inf. 2003;79:68-71.

summary